• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Recipients of 2012 SAFE-Biopharma Digi Award named

Recipients of 2012 SAFE-Biopharma Digi Award named

April 30, 2012
CenterWatch Staff

Recipients have been selected for the 2012 SAFE-BioPharma Digi Award, recognizing innovative uses of the global SAFE-BioPharma digital identity and digital signature standard and the institutions and individuals contributing to broader understanding of its benefits. Recipients included: Astellas, Bristol-Myers Squibb and representatives of two U.S. government entities.

“The selected companies and individuals have helped advance the use and understanding of SAFE-BioPharma as a way to ensure trust in online identities and to apply legally-binding digital signatures to electronic documents,” said Mollie Shields-Uehling, president and CEO, SAFE-BioPharma Association. The board of directors of the non-profit consortium made the selections from nominations submitted from the biopharmaceutical, healthcare and information security sectors.

Astellas Pharma was selected for a SAFE-BioPharma virtual clinical study pilot project in Japan involving the Japan Medical Association Center for Clinical Trials and three general hospitals under Ibaraki Hospital Center of Hitachi. In the pilot, clinical trial contracts and IRB review reports were signed digitally by Astellas as a virtual sponsor and by medical professionals at the hospitals.

Steven Friedman, National Cancer Institute, and Cindy Cullen, Bristol-Myers Squibb, were selected for their participation in a pioneering use of interoperable digital identities by a small group of government and industry cancer researchers that demonstrates how clinical trial initiation can be accelerated while reducing costs.

Peter Alterman, Assistant CIO for EAuthentication, National Institutes of Health,was selected for playing a critical role (as chairman of the Federal PKI Policy Authority) in creating foundational tools for developing and promulgating use of interoperable digital identities by U.S. government employees and for ushering in the era of eSubmissions. The judges also cited Dr. Alterman’s leadership in laying the groundwork for conducting future paperless clinical trials

This is the first of what will become an annual nomination and selection process.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing